Synchron

Brooklyn, United States

Synchron is a bioelectronics medicine company that develops neuromodulation solutions for previously-untreatable nervous system conditions.

$200.0M raised

Nov 2025

Series D

Top Investors

Khosla VenturesAlumni VenturesARCH Venture PartnersK5 GlobalUniversity of Melbourne

19,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Synchron raised?

Synchron has raised $200.0M in total funding. The most recent round was Series D. The last funding was announced in November 2025.

Who are Synchron's investors?

Synchron's investors include Khosla Ventures, Alumni Ventures, ARCH Venture Partners, K5 Global, University of Melbourne.

Where is Synchron headquartered?

Synchron is headquartered in Brooklyn, United States.

What does Synchron do?

Synchron is a bioelectronics medicine company that develops neuromodulation solutions for previously-untreatable nervous system conditions.

What stage is Synchron at?

Synchron is at the Series D stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated November 6, 2025.

MLA

"Synchron — Funding & Investors." VCBacked, November 6, 2025, https://www.vcbacked.co/company/synchron. Accessed June 4, 2026.

APA

VCBacked. (2025). Synchron — Funding & Investors. Retrieved June 4, 2026, from https://www.vcbacked.co/company/synchron

Wikipedia (cite web)

{{cite web |title=Synchron — Funding & Investors |url=https://www.vcbacked.co/company/synchron |website=VCBacked |access-date=June 4, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated November 6, 2025.